Recorded Chinese product: 吡诺克辛钠滴眼液吡诺克辛钠滴眼液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 湖北中佳药业有限公司Chinese legal name: 湖北中佳药业有限公司
主要成分Active Ingredients
- 吡诺克辛钠Binuo Kexin Na
- 辅料为Excipients recorded as
药物知识说明
吡诺克辛钠是一种在国家药监局注册认定的药品。该药品含有吡诺克辛钠-0c7b4317等成分。
该药品关联的活性成分包括：吡诺克辛钠Binuo Kexin Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：湖北中佳药业有限公司Chinese legal name: 湖北中佳药业有限公司。
您可以探索含有相同成分的其他药品：吡诺克辛钠-0c7b4317成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 吡诺克辛钠滴眼液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 吡诺克辛钠Binuo Kexin Na.
Manufacturers recorded for this product: 湖北中佳药业有限公司Chinese legal name: 湖北中佳药业有限公司.
Explore other medicines containing the same ingredient: 吡诺克辛钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 吡诺克辛钠滴眼液Recorded Chinese product: 吡诺克辛钠滴眼液
- 剂型Dosage form: 滴眼剂Eye drops
- 规格Specification: 15ml15 mL
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 湖北中佳药业有限公司Chinese legal name: 湖北中佳药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20065749
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20065749
Manufacturer
Chinese legal name: 湖北中佳药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20065749
生产企业
湖北中佳药业有限公司(国产)
适应症
主要治疗初期老年性白内障、轻度糖尿病性白内障或并发性白内障等。
用法用量
滴眼，每日3～4次，每次1～2滴。
不良反应
极少数患者可有轻微眼部刺激。
禁忌
眼外伤及严重感染时，暂不使用，或遵医嘱。
注意事项
1.使用前须将1片药片投入1瓶溶剂中，待药物完全溶解后，方可使用。片剂溶解入溶剂后，应连续使用，在20天内用完。
2.糖尿病引起的白内障患者，应在使用本品的同时，在医师指导下结合其他方法治疗。
3.滴眼时请勿使管口接触手和眼睛，避免污染瓶内眼药水。
4.本品宜避光保存；使用后请拧紧瓶盖，以防污染。
5.对本品过敏者禁用，过敏体质者慎用。
6.本品性状发生改变时禁止使用。
7.请将本品放在儿童不能接触的地方。
8.如正在使用其他药品，使用本品前请咨询医师或药师。
贮藏
遮光，密闭保存。
规格
15ml
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.